Wednesday, December 7, 2016

BRIEF-Abiomed Impella CP receives expanded FDA approval for high-risk percutaneous coronary intervention (PCI) procedures

* Has expanded FDA pre-market approval for impella heart

pump use in PCI to include impella cp heart pump

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)